The fungal metabolite Brefeldin 
Introduction
Vaccinia virus (VV) DNA replication and transcription take place in the cytoplasm of the infected cell using a panel of virus-encoded enzymes and cofactors. In vitro infection of cells results in the production of two morphologically distinct types of progeny virions: intracellular naked virus (INV) and enveloped virus (EV), which exits the cell. Both forms acquire at least one, and possibly two, unit membranes derived from the intermediate compartment of the host cell (Sodeik et al., 1993) and in addition, the EV form acquires two further membranes by enwrapment with trans-Golgi cisternae to become intracellular enveloped virus (IEV) (reviewed by Moss, 1990) . IEV particles exit the cell through the plasma membrane, losing one of the Golgi-derived membranes in the process to become a mature EV particle. Recent publications have pointed out that intracellular naked virus is a misnomer for the 'nonenveloped' VV form, and have suggested that intracellular mature virus (IMV) be used instead for the infectious intracellular particle that has hitherto been referred to as INV (Sodeik et al., 1993; Schmetz et al., 1994) . We have adopted this new convention.
Virions which exit the cell either detach from the cell as extracellular enveloped virus (EEV) or remain * Author for correspondence. Fax +1 503 737 2440. e-mail ulaetod@bcc, orst. edu associated with the outside of the plasma membrane as cell-associated enveloped virus (CEV) (Blasco & Moss, 1992) . EEV and CEV, which we collectively refer to as EV, are responsible for the dissemination of the virus in tissue culture (and presumably in vivo) ; the function of IMV particles, despite constituting the majority of progeny virions in most tissue culture systems, is not known. EV particles possess several viral polypeptides that are absent in IMV particles, including proteins of 42 kDa and 37 kDa that have been shown to be essential for formation of infectious EV (Blasco & Moss, 1991; Engelstad & Smith, 1993; Wolffe et al., 1993) . Of these the 37 kDa protein, P37, is the best studied and has been proposed as a candidate envelopment receptor in the Golgi apparatus (Rodriguez & Smith, 1990 ). The protein is palmitylated but is not glycosylated and has been shown to colocalize with exogenously applied wheatgerm agglutinin (WGA) (Hiller & Weber, 1985) , a marker for the trans portion of the Golgi apparatus and the transGolgi network (TGN) (Lippincott-Schwartz et al., 1989) . In addition, recent data from other researchers has shown definitively that both P37 and gp42 are enriched in the TGN and that this compartment is where enwrapment to form IEV particles takes place (Schmelz et al., 1994) .
In the study reported here the antibiotic Brefeldin A (BFA) has been used to inhibit EV production to facilitate an analysis of the mechanism(s) of envelopment. BFA has previously been shown to block the transport of proteins across the Golgi to post-endo-plasmic reticulum (ER) locations with a concomitant redistribution of the cis and medial compartments of the Golgi apparatus to the ER. The mechanism for this appears to be an inhibition of association of transport vesicle coatomer proteins with Golgi and ER membranes, preventing the formation of transport vesicles that traffic between these compartments (Robinson & Kreis, 1992; Narula et al., 1992) . Resident and transiting Golgi proteins accumulate in the ER as cis and medial Golgi membranes recycle to the ER via a retrograde transport pathway. Thus, the components of the cis and medial Golgi and the enzyme activities that are associated with these compartments are found in the ER during BFA treatment. The inhibition is completely reversible, with normal trafficking resuming within minutes of removal of the drug (Lippincott-Schwartz et al., 1989 .
As might be expected, BFA has an inhibitory effect on the maturation of certain enveloped viruses such as herpes simplex virus and cytomegalovirus (Cheung et al., 1991; Eggers et al., 1992) , and the inhibitory effect on envelopment appears to be directly related to the BFAmediated block on intracellular transport through the Golgi apparatus. A similar situation is unlikely to be the case for VV as, although VV EV particles obtain their envelope from the TGN, the particles do not appear to use the exocytic pathway as the major route for egress. Instead a cytochalasin-sensitive, microfilament-mediated mechanism is used to transport the enveloped particles to the plasma membrane (Stokes, 1976) .
As the two infectious forms of VV possess membranes it is reasonable to suppose that BFA might disrupt the maturation of one or both. As IMV particles are not known to contain Golgi-modified glycoproteins it is furthermore reasonable to suppose that any effects of BFA might be differentially manifested in the two forms. There are several possible mechanisms by which a differential effect could be mediated. One is a direct effect on P37, preventing its association with intracellular membranes in a fashion similar or analogous to the effect of the drug Nl-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine (IMCBH) (Hiller et al., 1981) , or altering the topography of the protein in or on cellular membranes such that it can no longer perform its normal function. A third possibility is an indirect effect on P37, preventing post-translational modification of the protein which may be required for function. P37 is the major palmitylated protein of VV (Hiller & Weber, 1985; Child & Hruby, 1992) . There is some evidence to suggest that palmitylation occurs on or in intracellular membranes (Schmidt & Burns, 1989) . Thus it is possible that BFAmediated perturbation of membrane trafficking might result in a failure of the protein to acquire palmitic acid modification. A further possibility is that any effects of BFA on EV production that are not also observed on IMV production are due to the retention of essential EV glycoproteins in the ER under BFA treatment. If the final hypothesis is correct, we reasoned that application of BFA to infected cultures might disrupt EV egress owing to retention of essential EV glycoproteins in the ER, but would not be expected to affect envelope acquisition if P37, which does not acquire cis-medial Golgi modifications, is the envelopment receptor on TGN membranes. To test these hypotheses, experiments were performed in which BFA was used to inhibit production of EV, and progeny virions were analysed by electron microscopy and CsC1 density centrifugation to determine whether IEV particles accumulated under these conditions. In addition the effects of BFA on posttranslational modification and membrane association of P37 were examined.
Methods
Cell lines and viruses. Monolayers of RK13 (rabbit kidney), BHK (baby hamster kidney) and BSC40 (African green monkey kidney) epithelial cell lines were maintained in Eagle's MEM (Sigma) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Whittaker Bioproducts), 2mM-L-glutamine and 50mM-gentamicin sulphate at 37 °C in a 5 % CO 2 humidified atmosphere. The IHD-J strain of VV was grown and purified as previously described (Hruby et al., 1979) , with the exception that EEV particles were collected by centrifugation of the clarified culture supernatant from infected cells prior to further purification procedures. Viruses were quantitated by plaque titration of probe-sonicated virus suspensions on confluent monolayers of BSC40 cells.
Drugs. BFA was purchased from Sigma and was stored at --70 °C as 1 or 5 mg/ml solutions in 75 % ethanol. In all cases when BFA was used in tissue culture medium, the medium was first buffered by the addition of HEPES (pH 7.5) to a concentration of 10 mM. In all cases where BFA-treated cells were harvested BFA was maintained in the medium until cell fractionation was complete. Lysates of BFA-treated cells were prepared in medium containing 10 gg/ml BFA.
Antisera. Rabbit antiserum to P37 was kindly provided by Dr R. Wittek, University of Lausanne. Previously characterized rabbit antiserum to p4a was generated to a trpE fusion protein (VanSlyke et al., 1991) .
Caesium chloride density gradients. CsC1 gradients were prepared with premixed solutions of 1.20, 1.25 and 1.30 g/ml density. Of each solution 1.6, 2.1 and 1.6 ml, respectively, was underlayered in a 5'5 ml Beckman Quickseal centrifuge tube. A 200 gl volume of virus suspension was mixed with the 1.20 g/ml CsCI solution prior to addition to the tube, and the gradient centrifuged in a Beckman vti. 80 rotor at 100 000 g for 1 h at 15 °C. After centrifugation, fractions were collected from the bottom of the tube under the control of a peristaltic pump. England Nuclear, 1128 Ci/mmol) or 200 ~tCi/ml [9,10-3H]palmitic acid (New England Nuclear, 38 Ci/mmol). At 8 h p.i. cells were released from the monolayers with a rubber policeman. The cells were collected in PBS, pelleted by centrifugation at 1300 r.p.m, in a bench-top centrifuge and resuspended in 1 ml of fresh PBS. Samples were frozen at -70 °C overnight. After thawing, cell lysates were prepared by probe sonication and used immediately.
Radiolabelling of VV-infected cells.
For labelling of virions containing newly synthesized viral DNA, confluent monolayers were infected at an m.o.i, of 5 in 9 cm tissue culture dishes. At 0 h p.i. 10 gCi of [3H]thymidine was added to each dish. At 24 h p.i. cells were harvested in the original culture medium and lysed by probe sonication. Nuclei were removed by centrifugation at 900g for 10min at 4 °C. Virus was separated from radiolabelcontaining culture medium by centrifugation at 40000 g for 80 min over a cushion of 36 % sucrose. Virus particles were collected from the pellet.
Preparation of intracellular membranes and proteinase K digestion.
Intracellular membranes were prepared from VV-infected cells at 9 h p.i. To avoid loss of VV proteins in insoluble aggregates, total cell lysates were diluted to 7.5 ml in PBS and layered carefully onto a cushion of 4-5 ml of 50 % (w/v) sucrose. Discontinuous gradients were centrifuged in a Beckman SW41 rotor at 100000 g at 4 °C for 30 min. After centrifugation, tubes were placed in an ISCO fractionator and pierced from the bottom. Gradients were lifted out of tubes on a cushion of 60 % (w/v) sucrose and fractions collected from the top of the tube in 1 ml volumes. When the gradient had been completely harvested the pellet of insoluble material in the bottom of the tube was harvested and washed in PBS. When only the pellet and/or sample/ sucrose interface were required, gradients were harvested manually with a Pasteur pipette. Manually collected interface samples were diluted in PBS and recentrifuged under the same conditions to form a pellet that was collected in an appropriate volume of buffer.
For experiments utilizing proteinase K, cell lysates were centrifuged at 900 g for 10 min at 4 °C to obtain a nuclear pellet and a post-nuclear supernatant containing the Golgi apparatus. Post-nuclear supernatants were incubated with proteinase K (Boehringer Mannheim) at 10 gg/ml on ice for varying amounts of time after which the digestion was terminated by addition of 1 mM-PMSF for 30 s on ice and then boiling for 5 min.
Immunoprecipitations. Immunoprecipitations were performed in 1% (w/v) sodium deoxycholate, 1% (v/v) Triton X-100, 0.2 % (w/v) SDS, 150 mM-NaC1 and 50 mM-Tris-HC1 pH 7.4 (RIPA buffer). Samples were either resuspended in RIPA buffer or adjusted with a 10 × RIPA buffer stock solution. Samples were boiled in RIPA buffer for 3 min and clarified by microcentrifugation at 16000g for 1 min. Clarified samples were adjusted to 5 mg/ml BSA and 2 gl/ml specific rabbit antiserum. Samples were vortexed briefly and incubated on ice for 2 h. After incubation on ice, 200 gl of a 10 % (v/v) suspension of washed, preswollen Protein A-Sepharose beads (Sigma) was added to each reaction. The samples were further incubated at 4 °C for 18 h with constant agitation. Beads were washed three times with RIPA buffer and finally resuspended in SDS~PAGE sample buffer.
SDS-PAGE and fluorography. Discontinuous SDS-PAGE was
performed with 10 % polyacrylamide gels under denaturing conditions using a glycine-buffered gel system (Laemmli, 1970) or a tricinebuffered gel system (tricine-SDS-PAGE) (ScMgger &von Jagow, 1987) . For detection of radiolabelled proteins, gels were equilibrated with 22.2 % PPO in DMSO, dried and exposed to Kodak XAR-5 X-ray film at -70 °C (Bonner & Laskey, 1974) . Incorporated label was directly quantitated with an AMBIS radioanalytic imaging system.
Western blotting. Western blots were performed essentially by the method of Towbin et al. (1979) . Polyacrylamide gels from SDS-PAGE procedures were equilibrated with 25 mM-Tris base, 192 mM-glycine
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105 and 20 % (v/v) methanol. Proteins were electroblotted from gels to nitrocellulose filters in the same buffer. Filters were washed with 20 mM-TribHC1, 500 mM-NaC1, pH 7.5 (TBS) and excess binding capacity was adsorbed with the same buffer supplemented with 3 % gelatin. Primary and secondary antibodies were applied in TBS supplemented with 0.05 % (v/v) Tween-20 and 1% (w/v) gelatin. The secondary antibody was goat anti-rabbit immunoglobulin conjugated to alkaline phosphatase (Bio-Rad) and was visualized using a nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP) detection system (Bio-Rad).
Electron microscopy. For electron microscopy (EM) studies, infected cells were released from monolayers with rubber policemen, washed in PBS and incubated with 2.5% glutaraldehyde for 4h at room temperature. After overnight incubation in cacodylate buffer (0.2 M pH 7.2) samples were post-fixed with 1% osmium tetroxide and counterstained with uranyl acetate. Samples were then embedded in Spurr's resin prior to sectioning.
Results

The effect of BFA on virion production
Different combinations of VV strain and host cell line produce different ratios of EEV and CEV progeny (Payne, 1979; Blasco & Moss, 1992) . The combination of VV-IHD-J and RK13 cells produces the greatest quantity of EEV relative to CEV and was therefore chosen for our experiments. Confluent monolayers of RK13 cells were infected with VV-IHD-J at an m.o.i, of 5 and the cells cultured for varying lengths of time up to 24 h p.i. Production of progeny virions reaches a plateau at approximately 15 h p.i., with EEV production lagging slightly behind that of IMV (Fig. 1 a) . Application of BFA to synchronously infected cultures at 0 h p.i. results in a 1000-fold reduction in the quantity of infectious EEV produced over a 24 h p.i. period, at concentrations of BFA as low as 0.1 ~tg/ml with no apparent effect on IMV production (Fig. l b) . IMV production is unaffected at BFA concentrations as high as 10 gg/ml (data not shown).
Further analyses were performed to examine the possibility that BFA causes an increase in CEV or IEV production concomitant with the observed decrease in EEV production. IEV particles and particles in the act of exiting the cell were observed by electron microscopic analysis of sections through untreated, VV-IHD-Jinfected RK13 cells at 8 h p.i. However, examination of sections from parallel cultures treated with BFA from 0 h p.i. did not reveal any CEV or IEV particles despite extensive searches (data not shown). In addition, CsC1 density centrifugation of total progeny virions from untreated and BFA-treated cultures was used to determine the presence or absence of low-density EV and IEV particles. For these experiments kidney epithelial cell lines from three different species (rabbit, RK13; hamster, BHK and African green monkey, BSC40) were utilized to provide a control for possible species and monolayers (O) were harvested from replicate cultures. Supernatant samples were subjected to centrifugation for 30 min at 16000 g at 4 °C to pellet the virus particles. Virus particles were then resuspended in PBS to remove BFA from the sample. All samples were subjected to three cycles of freeze/thaw in PBS and probe sonicated to disaggregate clumped virions. Samples were adjusted to equal volumes and progeny virions quantified by plaque titration on confluent monolayers of BSC40 cells. Data are presented as the mean of triplicate cultures. (b) BFA-mediated inhibition of EEV production. Confluent monolayers of RK 13 cells in 24-well tissue culture plates were infected with IHD-J as in (a). BFA was added at 0h p.i. at varying concentrations in triplicate wells. At 24 h p.i. the progeny virions were harvested from culture supernatant (/k) and monolayers (O) and quantified as described in (a). Data are presented as the mean of triplicate cultures. differences in the effects of BFA on the exocytic pathway. Infected cells were cultured in the presence of [aH]thymidine for 24 h p.i. Total progeny virions from the infected cells and the tissue culture supernatant were harvested together and ultracentrifuged through a cushion of 36 % sucrose. The virus preparation was then ultracentrifuged through a CsC1 gradient in which IMV, EV and IEV particles will sediment with distinct densities due to the different ratios of protein to lipid that result from particles possessing different numbers of membranes. In gradients obtained from untreated cultures a major high-density peak representing IMV is observed with a smaller, lower density peak representing EV and, in some cultures, a third even lower density peak representing IEV. However in gradients obtained from BFA-treated cultures, only a high density IMV peak is observed (Fig. 2) . Similar profiles are obtained when gradient fractions obtained from all three cell lines are assessed by plaque titration instead of liquid scintillation counting (data not shown).
The effect of BFA on membrane association and posttranslational modification of EV-essential protein P37
The apparent failure of BFA-treated cells from three different species to make IEV or EV prompted an examination of the effect of the drug on viral protein P37, the candidate envelopment receptor that associates with membranes of the TGN. The effect of BFA on the presence or absence of the protein in association with intracellular membranes in VV-IHD-J-infected RK13 cells was examined. Synchronously infected cultures were harvested at 8 h p.i. and the cells disrupted by probe sonication. Total cell extracts were centrifuged over a cushion of 36% sucrose. It was anticipated that P37 associated with intracellular membranes would be concentrated at the sample/sucrose interface, whereas P37 molecules that failed to make such an association would be distributed throughout the supernatant above the sample/sucrose interface. In total cell extracts from untreated RK13 cells P37 is concentrated in two major peaks, at the interface and in a pellet of insoluble material. In extracts from BFA-treated cultures a greater proportion of the P37 is found in the insoluble pellet, but in neither case is P37 found as a soluble protein distributed through the supernatant (Fig. 3) . In contrast to the differential distribution of P37 between interface and pellet fractions in samples obtained from RK 13 cells in the presence and absence of BFA, when BHK and BSC40 cells are used the majority of the P37 is found in the interface fraction under both drug treatment and drug-free culture conditions (Fig. 4) .
P37 is the major palmitylated protein of VV (Child & Hruby, 1992) . It was therefore of interest to determine whether P37 is subject to palmityl modification in the presence of BFA. Because of the possibility that the membrane association of P37 might be artefactually disturbed in RK13 cells cultured with BFA (see Fig. 3  and 4) , subsequent analyses were performed in BHK cells. Confluent monolayers of BHK cells were infected with VV-IHD-J at an m.o.i, of 5. Infected cultures were maintained until 8 h p.i. in the presence of [3H]palmitic acid and the presence or absence of 2 ~tg/ml BFA. Cells were harvested and subjected to probe sonication prior to analysis by SDS-PAGE and fluorography. In both untreated and BFA-treated samples a major radiolabelled band corresponding to P37 is seen after SDS-PAGE and fluorography of total cell extracts (Fig. 5) .
A final biochemical analysis was made to determine whether the geometry of the association of P37 with intracellular membranes is altered in BFA-treated cells. Post-nuclear supernatants were generated from lysates of untreated and BFA-treated BHK cells synchronously infected with VV-IHD-J. Each post-nuclear supernatant was incubated with proteinase K and aliquots were removed at various time points for analysis by SDS-
PAGE and Western blotting procedures. Probing of
Western blots with specific antiserum revealed a band corresponding to P37 in all proteinase K-treated samples (Fig. 6a) . In contrast, when Western blots were probed with an antiserum reactive with the virus core protein precursor p4a (VanSlyke et al., 1991) , it was observed that p4a is degraded by as little as 5 min incubation with proteinase K (Fig. 6b) . The cell lysis procedure for these experiments utilized brief probe sonication on a low output setting. If high outputs or extended periods of sonication were used, P37 in post-nuclear supernatants acquired increasing sensitivity to proteinase K, which is assumed to reflect the formation of inverted vesicles from intracellular membranes (data not shown). In addition, incubation of post-nuclear supernatants with detergent to disrupt membranes rendered P37 fully sensitive to proteinase K digestion over a 5 min period (data not shown). 10 laCi of [3H]thymidine was added to culture media. At 24 h p.i. the cells were harvested and progeny virions liberated by probe sonication in the original tissue culture medium. Virus suspensions were centrifuged through a cushion of 36 % sucrose at 40000 g for 80 min. Virus pellets were resuspended and centrifuged over preformed CsC1 gradients as described in the Methods and the gradients were mechanically fractionated. The density of collected fractions was determined by refractometry and progeny virions were quantified by liquid scintillation counting of fractions harvested onto filters with a cell harvester (Skatron Instruments). One representative of four experiments is shown. in PBS or PBS supplemented with 10 ~tg/ml BFA, respectively. Cell lysates were centrifuged on discontinuous sucrose gradients as described in Methods and mechanically fractionated. Fractions were subjected to immunoprecipitation with anti-P37 antiserum followed by SDS-PAGE and fluorography (P = pellet). Immunoprecipitated P37 was identified on fluorographs and incorporated label was quantitated with an AMBIS radioanalytic imaging system. One representative of two experiments is shown.
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D i s c u s s i o n
The mechanisms of envelopment and egress in the Poxviridae are poorly understood. In VV, the prototype member, a number of proteins and glycoproteins have been identified that are unique to the EV form of the virus. Two of these proteins, P37 and glycoprotein gp42, have been shown to be essential for the production of progeny EV in vitro (Blasco & Moss, 1991 ; Engelstad & Smith, 1993 ; Wolffe et al., 1993) . The precise functions of P37 and gp42 have not yet been determined, although because of its association with T G N membranes, P37 has been suggested as a candidate envelopment receptor which may mediate an interaction between these membranes and virions targeted for envelopment (Rodriguez & Smith, 1990) . We have observed that the fungal antibiotic BFA inhibits the production of EV in VVinfected cells. This effect is apparently not due to an inhibition of virus egress as IEV particles do not accumulate in drug-treated cells, as determined by EM or CsC1 density gradient analysis of progeny virions; nor is it due to a defect in virus assembly, as the production of IMV particles is not affected. Thus the drug block appears to operate at the stage of envelopment. Other researchers have observed a similar phenomenon with an alternative drug, I M C B H (Payne & Kristenson, 1979) . A mutation resulting in resistance to IMCBH has been shown to map to a single amino acid change in P37, and the intracellular distribution of wild-type P37 is altered in IMCBH-treated cells, taking up a diffuse pattern of staining in immunofluorescence (Hiller et al., 1981; Schmutz et al., 1991) . Therefore we performed an analysis of the effect of BFA treatment on the membrane association of P37. It was observed that BFA treatment did not prevent the association of P37 with intracellular membranes, nor did it prevent the modification of the protein by addition of palmitic acid. In addition the protein isolated from both BFA-treated and untreated cultures was found to be proteinase K-resistant in lysates of infected cells, suggesting that the geometry of the association between intracellular membranes and P37 is relatively unaltered by the drug treatment, and that P37 is associated with the lumenal rather than the cytosolic face of an intracellular membrane-bound compartment. . Proteinase K digestion of membrane-associated P37. Intracellular membranes from IHD-J-infected BHK cells maintained in the presence or absence of 1 gg/ml BFA were prepared as described in Methods, with the exception that samples were not subjected to freeze/thaw but were utilized immediately. Post-nuclear supernatants were divided into two equal portions and either treated with 10 pg/ml proteinase K on ice or incubated with PBS under identical conditions. After termination of the reaction samples were subjected to tricine-SDS-PAGE and Western blotting procedures. Western blots were probed with rabbit antiserum to P37 (a) or viral protein p4a (b). All samples from BFA-treated cultures were maintained in the presence of 10 pg/ml BFA until dissolution in SDS PAGE sample buffer. Lysates from untreated cultures were adjusted to 0"15% ethanol, the final concentration of ethanol in the lysates from the BFA-treated cultures. Samples were treated with proteinase K for 0, 5, 15, 30 or 60 min and loaded in lanes 1 5 and 6-10 respectively. Lanes 1-5, untreated cultures; lanes 6-10, BFA-treated cultures. One representative of two experiments.
T h i s fits well w i t h o t h e r d a t a d e m o n s t r a t i n g t h a t o n m a t u r e E V p a r t i c l e s P 3 7 is sensitive to p r o t e i n a s e K ( R a v a n e l l o & H r u b y , 1994). B e c a u s e v i r i o n s a r e enw r a p p e d w i t h T G N c i s t e r n a e r a t h e r t h a n b u d d i n g t h r o u g h i n t o t h e l u m e n o f t h e c o m p a r t m e n t , a p r o t e i n t h a t w a s l o c a t e d o n t h e l u m e n a l face o f t h e c o m p a r t m e n t w o u l d b e e x p e c t e d to b e o n t h e e x t e r n a l face o f t h e E V s e c o n d m e m b r a n e , a n d t h u s sensitive to p r o t e i n a s e K o n m a t u r e E V , b u t r e s i s t a n t to it o n G o l g i m e m b r a n e s . O u r d a t a h a v e t h u s failed to d e m o n s t r a t e a n y effect o f B F A o n t h e E V p r o t e i n P37. T h i s suggests t h a t t h e f u n c t i o n o f t h e p r o t e i n i n t h e v i r u s life cycle m a y n o t b e as a n e n v e l o p m e n t r e c e p t o r o n T G N m e m b r a n e s .
T h e d a t a o b t a i n e d a r e c o n s i s t e n t w i t h a n e n v e l o p m e n t 5) . The identity of this protein has not been confirmed, however it has been suggested to be gp42, which is known to be palmitylated in untreated cultures (Child & Hruby, 1992; Payne, 1992) . If this protein is indeed gp42, failure to palmitylate in BFA-treated cells (where P37 is palmitylated normally) is suggestive of segregation of the two proteins into different subcellular locations. These issues bear further investigation, including a biochemical and kinetic analysis of the covalent association of P37 and gp42 in infected cells and mature EV particles, which is ongoing in our laboratory. In summary, we have demonstrated that BFA, a drug which inhibits the acquisition of a TGN-derived envelope by intracellular VV particles, has no apparent effect on the membrane association of the EV-restricted protein P37. In both untreated and drug-treated cells, membrane associated P37 does not appear to be exposed to the cytosol where an interaction with virions about to be enveloped would have to occur. This suggests that P37 alone does not act as a recognition structure for virion envelopment on intracellular membranes, although it does not rule out the possibility that the protein forms part of a complex of virus and/or cellular proteins which facilitate virion envelopment.
